Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405613 · ClinicalTrials.gov registry record · Phase 2
Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT00405613 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 36 participants.
The verdict
NCT00405613, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if aspirin is associated with bleeding complications following a single tooth extraction
Interventions
- DRUG Aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00405613
The ClinicalTrials.gov registry entry for NCT00405613 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aspirin is the first listed.
NCT00405613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00405613 about?
NCT00405613 is a clinical study titled "Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population". The purpose of this study is to determine if aspirin is associated with bleeding complications following a single tooth extraction
What is the current status of trial NCT00405613?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2003-05. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00405613?
The interventions under investigation include: Aspirin (DRUG).
Who is sponsoring clinical trial NCT00405613?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.